2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Delayed Graft Function: new trials by email Literature Review of Delayed Graft Function trials Research Report on Delayed Graft Function
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Heme Arginate in Transplantation Study Heme Arginate 25 MG/ML, 0.9% Sodium-chloride - Renal Transplant Rejection, Renal Transplant Failure | Phase 3 | Terminated | University of Edinburgh | 47 | 2019-03-12 | 2025-11-17 |
| A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys Everolimus, Tacrolimus, Mycophenolate mofetil (MMF/MPA) - Delayed Graft Function | Phase 2 / Phase 3 | Terminated | Matthew Cooper | 25 | 2013-06-01 | 2019-04-26 |
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Everolimus (1) · Mycophenolic Acid (1) · Sodium Chloride (1) · Tacrolimus (1) · heme arginate (1)
Matthew Cooper (1) · University of Edinburgh (1)
United Kingdom (1) · United States (1)
Lorna Marson (1) · Matthew Cooper (1)